摘要:
The complex consists of LVPs associated with human immunoglobulins having a density of less than 1.063 g/ml. It may be obtained by a method according to which a plasma or serum sample taken from a patient infected with HCV is made available, the LVPs are separated from the said sample by centrifugation according to their density, and the LVPs associated with human immunoglobulins are separated using protein A, anti-human immunoglobulins or any other molecule capable of binding human immunoglobulins.
摘要:
A search method in a biological sample containing an HIV 2 viral strain for possible resistance of said strain to treatment by an anti-protease agent, and nucleotide probes for the implementation thereof. According to methods known per se, the presence of at least one mutation at certain, specified, particular positions of the proteinic sequence of the protease of said viral strain from a biological sample taken from a patient contaminated by HIV 2 is searched. If said mutation is observed, the existence of a resistance to said anti-protease agent is assumed in the patient.
摘要:
The present invention relates to a temperature-stable labeling reagent of formula: 1 in which R1 represents H or an alkyl, aryl or substituted aryl group, R2 represents a detectable marker or at least two detectable markers linked together by at least one multimeric structure, L is a linking arm containing a linear succession of at least two covalent bonds and n an integer equal to 0 or 1, R3 and R4 represent independently of each other: H, NO2, Cl, Br, F, I, R2-(L)n-YnullXnull, OR, SR, NR2, R, NHCOR, CONHR, COOR with Rnullalkyl or aryl, A is a linking arm containing at least one covalent double bond allowing conjugation of the diazo functional group with the aromatic ring and u is an integer between 0 and 2, preferably equal to 0 or 1, and nullYnullXnull represents nullCONHnull, nullNHCOnull, nullCH2Onull, nullCH2Snull. The present invention also describes a method for synthesizing said markers as well as applications for labeling biological molecules, in particular nucleic acids, with a labeling reagent carrying the diazomethyl functional group. The invention finds a preferred application in the field of diagnosis.
摘要:
The invention concerns a method of culturing, propagating and replicating in vitro viruses of the Togaviridae and Flaviviridae families which consists in: providing at least a fraction of LVP's obtained from serum or plasma of a patient infected with a least a virus of the Togaviridae and Flaviviridae families; contacting said fraction, for a predetermined time interval in an appropriate culture medium, with permissive cells having an endocytosis path relayed by at least one receptor of the lipoproteins and modulated inter alia by an activating agent selected among an unsaturated fatty acid or an unsaturated fatty acid derivative comprising 16 to 20 carbon atoms or their mixture. The invention also concerns the uses of viral particles and polypeptides obtained by said method.
摘要:
The invention relates to a nucleotide fragment of a LTR-RU5 region comprising a nucleotide sequence which encodes the expression of a protein, wherein said protein comprises a peptide sequence selected from SEQ ID NO:2, SEQ ID NO:3 and SEQ ID NO:4, and a complementary nucleotide fragment; a probe and a primer hybridizing with said fragment; a protein encoded by said fragment; an antibody directed against said protein; and a process for detecting the presence of MSRV-1 retrovirus using a probe or an antibody of the invention.
摘要翻译:本发明涉及包含编码蛋白质表达的核苷酸序列的LTR-RU5区域的核苷酸片段,其中所述蛋白质包含选自SEQ ID NO:2,SEQ ID NO:3和SEQ ID NO: 4和互补核苷酸片段; 探针和与所述片段杂交的引物; 由所述片段编码的蛋白质; 针对所述蛋白质的抗体; 以及使用本发明的探针或抗体检测MSRV-1逆转录病毒的存在的方法。
摘要:
An oligopeptides comprising the following sequence Thr Gln Cys His Cys Gly Lys Cys (SEQ ID NO: 5) may be used as an antigenic compound capable of being recognized by anti-ovary antibodies and as an immunogenic compound capable of inducing the production of anti-ovary antibodies. In addition, the oligopeptides may be used to detect and/or quantify anti-ovary antibodies.
摘要翻译:包含以下序列的寡肽Thr Gln Cys His Cys Gly Lys Cys(SEQ ID NO:5)可以用作能够被抗卵巢抗体识别的抗原性化合物,并且可以作为能诱导产生抗卵巢抗体的免疫原性化合物, 卵巢抗体。 此外,寡肽可用于检测和/或定量抗卵巢抗体。
摘要:
The invention provides viral material and nucleotide fragments associated with multiple sclerosis and/or rheumatoid arthritis for use in methods of diagnosis, prophylaxis, and therapy.
摘要:
The present invention relates to a process for labeling a synthetic or natural ribonucleic acid (RNA). It also relates to RNA fragments, which have been labeled by fragmenting the RNA to free a terminal phosphate of each fragment for further reaction, and labeling each fragment at the freed terminal phosphate which is located at the 3null end and/or the 5null end of each fragment of the RNA, and to the use of such RNA fragments, for example, in the field of medical diagnosis.
摘要:
Viral material, in the isolated or purified state, in which the genome comprises a nucleotide sequence chosen from the group including sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, their complementary sequences and their equivalent sequences, in particular nucleotide sequences displaying, for any succession of 100 contiguous monomers, at least 50% and preferably at least 70% homology with the said sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, respectively, and their complementary sequences.
摘要翻译:分离或纯化状态的病毒物质,其中基因组包含选自SEQ ID NO:46,SEQ ID NO:51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:53的核苷酸序列 SEQ ID NO:46,SEQ ID NO:56,其互补序列及其等同序列,特别是核苷酸序列,显示100个连续单体的任何连续序列,与所述序列SEQ ID NO:46,SEQ ID NO为至少50%,优选至少70% :51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:56及其互补序列。
摘要:
The invention relates to a method for labeling and fragmenting a single- or double-stranded deoxyribonucleic acid (DNA) comprising the following steps: chemically fragmenting the DNA by creating at least one abasic site on said DNA, attaching a marker to at least one of the fragments by means of a labeling reagent, said reagent covalently and predominantly coupling to at least one phosphate of said fragment. The invention finds a preferred application in the field of diagnosis.